|
Volumn 22, Issue 6, 2001, Pages 273-276
|
Is paradoxical pharmacology a strategy worth pursuing?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;
ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DOPAMINE RECEPTOR BLOCKING AGENT;
ALZHEIMER DISEASE;
ASTHMA;
CONGESTIVE HEART FAILURE;
CONTROLLED STUDY;
DEGENERATIVE DISEASE;
DESENSITIZATION;
DRUG EFFECT;
EXERCISE;
HEART INFARCTION PREVENTION;
HEART PROTECTION;
HUMAN;
HYPERTENSION;
LONG TERM CARE;
PHYSICAL STRESS;
PRIORITY JOURNAL;
PROPHYLAXIS;
REVIEW;
SCHIZOPHRENIA;
ADRENERGIC ALPHA-AGONISTS;
ADRENERGIC ALPHA-ANTAGONISTS;
ADRENERGIC BETA-AGONISTS;
ADRENERGIC BETA-ANTAGONISTS;
ASTHMA;
HEART FAILURE, CONGESTIVE;
HUMANS;
HYPERTENSION;
PHARMACOLOGY, CLINICAL;
|
EID: 0035369309
PISSN: 01656147
EISSN: None
Source Type: Journal
DOI: 10.1016/S0165-6147(00)01711-9 Document Type: Review |
Times cited : (57)
|
References (22)
|